Aerpio Therapeutics

Small molecules for the treatment of diabetic macular edema.

placeCincinnati, Ohio, United States calendar_todayFounded 2011 groups12 employees language aerpio.com

Registered entities

Investor mix

14 investors on record; lead investors include Novartis Venture Fund, Orbimed, Kearny Venture Partners, Venture Investors.

Investor typeCountShare
Venture capital1179%
Private equity17%
Other / undisclosed214%
Coming soon